Matthew Mahoney

1.4k total citations · 1 hit paper
17 papers, 826 citations indexed

About

Matthew Mahoney is a scholar working on Molecular Biology, Organic Chemistry and Neurology. According to data from OpenAlex, Matthew Mahoney has authored 17 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Neurology. Recurrent topics in Matthew Mahoney's work include Synthesis and biological activity (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Alzheimer's disease research and treatments (2 papers). Matthew Mahoney is often cited by papers focused on Synthesis and biological activity (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Alzheimer's disease research and treatments (2 papers). Matthew Mahoney collaborates with scholars based in United States, India and Poland. Matthew Mahoney's co-authors include Marvin J. Meyers, David R. Anderson, David B. Reitz, William F. Vernier, Robert J. Mourey, Ravi G. Kurumbail, Nicole Caspers, Gennadiy Poda, Nicole Scott‐Hewitt and Beth Stevens and has published in prestigious journals such as Cell, The EMBO Journal and Journal of Virology.

In The Last Decade

Matthew Mahoney

15 papers receiving 811 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia

2020 285 citations Nicole Scott‐Hewitt, Fabio Perrucci et al. The EMBO Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Mahoney United States	12	406	231	219	133	103	17	826
Jeffrey M. Axten United States	16	933 2.3×	92 0.4×	322 1.5×	115 0.9×	146 1.4×	29	1.9k
Lorraine Morlock United States	17	583 1.4×	50 0.2×	93 0.4×	80 0.6×	148 1.4×	18	1.0k
Henri Mattes Switzerland	17	507 1.2×	47 0.2×	247 1.1×	101 0.8×	60 0.6×	29	915
K. Vijayalakshmi India	17	221 0.5×	104 0.5×	65 0.3×	22 0.2×	123 1.2×	38	782
Ulrich Pehl Germany	18	470 1.2×	58 0.3×	39 0.2×	119 0.9×	125 1.2×	25	918
Chunting Qi China	9	526 1.3×	78 0.3×	20 0.1×	216 1.6×	78 0.8×	15	706
Isak Im South Korea	12	295 0.7×	59 0.3×	147 0.7×	58 0.4×	99 1.0×	16	534
Gelin Wang China	13	900 2.2×	27 0.1×	120 0.5×	40 0.3×	74 0.7×	19	1.3k
Corinne Schneider United States	12	333 0.8×	65 0.3×	76 0.3×	117 0.9×	264 2.6×	18	743
Camille Brochier United States	11	1.0k 2.6×	59 0.3×	134 0.6×	41 0.3×	50 0.5×	14	1.2k

Countries citing papers authored by Matthew Mahoney

Since Specialization

Citations

This map shows the geographic impact of Matthew Mahoney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Mahoney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Mahoney more than expected).

Fields of papers citing papers by Matthew Mahoney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Mahoney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Mahoney. The network helps show where Matthew Mahoney may publish in the future.

Co-authorship network of co-authors of Matthew Mahoney

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Mahoney. A scholar is included among the top collaborators of Matthew Mahoney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Mahoney. Matthew Mahoney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Elfawal, Mostafa A., Bruce A. Rosa, Matthew Mahoney, et al.. (2025). Anthelmintics Derived from the Kinase Inhibitor SGI-1776 for the Treatment of Gastrointestinal Worm Infections. ACS Infectious Diseases. 11(11). 3196–3211.

Mahoney, Matthew, Elizabeth Weiland, Zhenfu Han, et al.. (2025). Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1. European Journal of Medicinal Chemistry. 302(Pt 3). 118385–118385.

Elfawal, Mostafa A., Bruce A. Rosa, Matthew Mahoney, et al.. (2025). Discovery of Human PIM Kinase Inhibitors as a Class of Anthelmintic Drugs to Treat Intestinal Nematode Infections. ACS Infectious Diseases. 11(2). 506–517. 1 indexed citations

Boon, Adrianus C. M., Traci L. Bricker, Ethan J. Fritch, et al.. (2024). Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19. Journal of Virology. 98(5). e0190323–e0190323. 8 indexed citations

Scott‐Hewitt, Nicole, Matthew Mahoney, Youtong Huang, et al.. (2024). Microglial-derived C1q integrates into neuronal ribonucleoprotein complexes and impacts protein homeostasis in the aging brain. Cell. 187(16). 4193–4212.e24. 32 indexed citations

Mahoney, Matthew, Vishnu C. Damalanka, Paolo De Bona, et al.. (2024). Use of protease substrate specificity screening in the rational design of selective protease inhibitors with unnatural amino acids: Application to HGFA, matriptase, and hepsin. Protein Science. 33(8). e5110–e5110. 4 indexed citations

Tyagi, Rahul, Christina A. Bulman, Fidelis Cho‐Ngwa, et al.. (2021). An Integrated Approach to Identify New Anti-Filarial Leads to Treat River Blindness, a Neglected Tropical Disease. Pathogens. 10(1). 71–71. 12 indexed citations

Damalanka, Vishnu C., Jorine Voss, Matthew Mahoney, et al.. (2021). Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression. Journal of Medicinal Chemistry. 64(24). 18158–18174. 11 indexed citations

Scott‐Hewitt, Nicole, Fabio Perrucci, Raffaella Morini, et al.. (2020). Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia. The EMBO Journal. 39(16). e105380–e105380. 285 indexed citations breakdown →

10.

Avdoshina, Valeria, Matthew Mahoney, Sean F. Gilmore, et al.. (2020). HIV influences microtubule associated protein-2: potential marker of HIV-associated neurocognitive disorders. AIDS. 34(7). 979–988. 14 indexed citations

11.

Meyers, Marvin J., Susan L. Hockerman, Xiangyang Chen, et al.. (2010). Discovery of (3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy. Journal of Medicinal Chemistry. 53(16). 5979–6002. 77 indexed citations

12.

Anderson, David R., Marvin J. Meyers, Ravi G. Kurumbail, et al.. (2009). Benzothiophene inhibitors of MK2. Part 2: Improvements in kinase selectivity and cell potency. Bioorganic & Medicinal Chemistry Letters. 19(16). 4882–4884. 37 indexed citations

13.

Anderson, David R., Marvin J. Meyers, Ravi G. Kurumbail, et al.. (2009). Benzothiophene inhibitors of MK2. Part 1: Structure–activity relationships, assessments of selectivity and cellular potency. Bioorganic & Medicinal Chemistry Letters. 19(16). 4878–4881. 35 indexed citations

14.

Trujillo, John I., Marvin J. Meyers, David R. Anderson, et al.. (2007). Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2). Bioorganic & Medicinal Chemistry Letters. 17(16). 4657–4663. 130 indexed citations

15.

Trujillo, John I., H. T. Huang, William L. Neumann, et al.. (2007). Design, synthesis, and biological evaluation of pyrazinones containing novel P1 needles as inhibitors of TF/VIIa. Bioorganic & Medicinal Chemistry Letters. 17(16). 4568–4574. 16 indexed citations

16.

Anderson, David R., Marvin J. Meyers, William F. Vernier, et al.. (2007). Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2). Journal of Medicinal Chemistry. 50(11). 2647–2654. 135 indexed citations

17.

Penning, Thomas D., Mark A. Russell, Helen Y. Chen, et al.. (2002). Synthesis of Potent Leukotriene A₄ Hydrolase Inhibitors. Identification of 3-[Methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic Acid. Journal of Medicinal Chemistry. 45(16). 3482–3490. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact